Brief: Icosavax Initiates Phase 1 Trial Of IVX-A12 Against RSV And hMPV In Older Adults

Icosavax

04/10/2022 21:07

Oct 4 (Reuters) - Icosavax Inc  ICVX.O :
    * ICOSAVAX INITIATES PHASE 1 TRIAL OF IVX-A12 AGAINST RSV
AND HMPV
IN OLDER ADULTS
    * ICOSAVAX INITIATES PHASE 1 TRIAL OF IVX-A12 AGAINST RSV
AND HMPV
IN OLDER ADULTS
    * ICOSAVAX INC - PHASE 1 TOPLINE INTERIM RESULTS EXPECTED IN
MID-2023
    * ICOSAVAX INC - PHASE 2 INITIATION PLANNED TO FOLLOW IN 2H
2023

Source text for Eikon:  ID:nGNX5Z2p45 
Further company coverage:  ICVX.O 
 ((Reuters.Briefs@thomsonreuters.com;))